
How to Source Non-IMP Supplies for Clinical Trials
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP supplies for clinical trials
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP supplies for clinical trials
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on the industry now the regulation…
In the latest Industry Viewpoint, Howard Fingert speaks to CTA’s Elizabeth Williams about the challenges of patient recruitment
Francesco Spoto, Clinical Project Manager, explores the opportunities of using IRT solutions to manage blinded information in clinical trials
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations in Asia
Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has observed in various GCP inspections
Christopher J. Pace, PhD, Director of Infectious Diseases, GlobalData, assesses the impact of the GAIN Act
Ian Hoban, Pilatus Comparator Solutions, poses some key questions that should be front of mind and considered early on in…
Thank you for subscribing to Clinical Trials Arena